0001415889-24-008313.txt : 20240318
0001415889-24-008313.hdr.sgml : 20240318
20240318173730
ACCESSION NUMBER: 0001415889-24-008313
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230109
FILED AS OF DATE: 20240318
DATE AS OF CHANGE: 20240318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peetz Christopher
CENTRAL INDEX KEY: 0001614740
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 24760280
MAIL ADDRESS:
STREET 1: C/O TOBIRA THERAPEUTICS, INC.
STREET 2: 701 GATEWAY BOULEVARD, #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4-03182024_090320.xml
X0508
4
2023-01-09
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001614740
Peetz Christopher
C/O MIRUM PHARMACEUTICALS, INC.
950 TOWER LANE, SUITE 1050
FOSTER CITY
CA
94404
true
true
false
false
CHIEF EXECUTIVE OFFICER
0
Common Stock
2023-01-09
4
S
0
5159
20.6223
D
91953
D
Common Stock
208570
I
By The Peetz Family Trust
Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.
7,000 shares held indirectly by the reporting person were inadvertently reported on prior Form 4 filings as direct holdings. The reporting person's holdings on this Form 4 have been adjusted accordingly.
/s/ Judit Ryvkin, Attorney-in-Fact
2024-03-18